Dr. Jack S. Resneck

Dr. Jack S. Resneck Jr. is a dermatologist who cares for patients with a wide range of skin diseases. In research, areas of Resneck's studies include patient access to care, health care delivery and affordability, digital medicine and public health. His work has been published in prominent journals and attracted national media attention. Raised in Louisiana, Resneck received his bachelor's degree in public policy from Brown University. He earned his medical degree from UCSF, where he also completed a residency in dermatology and a fellowship in health policy. Resneck serves on the editorial board of the Journal of the American Academy of Dermatology. He chaired the World Medical Association's global 30-month process to revise and modernize the Declaration of Helsinki, the seminal document defining the ethical principles and protections governing medical research with human participants. He chaired the board of trustees of the American Medical Association (AMA) from 2018 to 2019 and served as AMA president from 2022 to 2023. He also has served on the board of the National Quality Forum and as president of the California Society of Dermatology and Dermatologic Surgery. Resneck is a passionate advocate for both doctors and patients. He frequently speaks as a champion of well-tested health care innovation and a more equitable health care system. Whether testifying before Congress about addressing health care dysfunction and burdens, advocating for easier patient access or leading the dermatology department, he seeks to build stronger, healthier communities by improving the lives of patients and the working environment for doctors in the United States. Resneck is also committed to educating future doctors. He chairs the UCSF Department of Dermatology and is the UCSF Bruce U. Wintroub Endowed Professor of Dermatology. He serves as affiliated faculty at the UCSF Philip R. Lee Institute for Health Policy Studies.

Dr. Resneck is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Nummular Eczema, Actinic Keratosis, Neurocutaneous Melanosis, and Giant Congenital Nevus.

Dr. Resneck is board certified in American Board Of Dermatology, Dermatology. He is actively involved in clinical research, co-authoring 32 peer reviewed articles. Dr. Resneck is currently accepting new patients.